Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27.4M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
+2.62M
-
Total reported value, excl. options
-
$101M
-
Value change
-
+$27.2M
-
Put/Call ratio
-
0.28
-
Number of buys
-
57
-
Number of sells
-
-29
-
Price
-
$9.99
Significant Holders of ICAD, INC. - Common Stock, $0.01 par value (ICAD) as of Q2 2020
106 filings reported holding ICAD - ICAD, INC. - Common Stock, $0.01 par value as of Q2 2020.
ICAD, INC. - Common Stock, $0.01 par value (ICAD) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 27.4M outstanding shares and own 37.08% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.38M shares), VANGUARD GROUP INC (944K shares), G2 Investment Partners Management LLC (815K shares), Parkman Healthcare Partners LLC (726K shares), FEDERATED HERMES, INC. (650K shares), RENAISSANCE TECHNOLOGIES LLC (557K shares), Fairpointe Capital LLC (323K shares), Russell Investments Group, Ltd. (322K shares), Ikarian Capital, LLC (312K shares), and EAM Investors, LLC (305K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.